期刊文献+

血栓抽吸联合替罗非班和维拉帕米预防急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗无复流的临床疗效研究 被引量:8

Efficacy of Thrombus Aspiration Combined with Tirofiban and Verapamil in Prevention of No-reflow in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的观察血栓抽吸联合冠状动脉内推注替罗非班、维拉帕米预防急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗(PCI)无复流的疗效及安全性。方法将我院收治的65例急性ST段抬高型心肌梗死患者随机分为联合治疗组34例和标准PCI组31例。联合治疗组:在Diver CE导管抽吸后经冠状动脉直接推注维拉帕米和替罗非班,再根据具体情况予以球囊扩张和/或支架术;标准PCI组:术前静脉推注替罗非班,然后静脉泵入替罗非班,维持24~48 h,术中如出现"慢血流"或"无复流"使用维拉帕米,予以球囊扩张和/或支架术。观察住院期间出血并发症及主要心血管事件。结果住院期间联合治疗组恶性心律失常和心脏破裂发生率均低于标准PCI组(P<0.05);两组均未发生严重出血并发症。结论血栓抽吸联合冠状动脉内推注替罗非班、维拉帕米预防急性ST段抬高型心肌梗死患者直接PCI无复流有效、安全。 Objective To observe the safety and efficacy of thrombus aspiration combined with intracoronary bolus tirofiban and verapamil in preventing no - reflow in patients with acute ST - segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (PCI). Methods 65 patients admitted to our hospital with acute ST- segment ele- vation myocardial infarction were randomly divided into combined treatment group of 34 cases and standard PCI group of 31 cases. Patients in combined treatment group were injected verapamil and tirofiban through coronary after thrombus aspiration by device Diver CE, and then given I balloon dilatation and/or stenting depending on the patients'condition; Patients in standard PCI group were injected tirofiban through venous before PCI, and then tirofiban infused, maintain for 24 -48 h, verapamil was given when slow flow " or" no - reflow occurred during the operation, and I balloon dilatation and/or stenting after. The incidence of major adverse cardiovascular events and hemorrhagic complications of the two groups were observed during hospitalization. Resuits During hospitalization, malignant arrhythmias and cardiac rupture in combined therapy group were lower than those of standard PCI group (P 〈 0. 05), and no hemorrhagic complications occurred. Conclusion Thrombus aspiration combined with tirofiban and verapamil in preventing no - reflow in patients with acute ST - segment elevation myocardial infarction undergoing primary PCI is safe and effective.
出处 《实用心脑肺血管病杂志》 2013年第12期29-31,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 血栓形成 抽吸 替罗非班 维拉帕米 血管成形术 经腔 经皮冠状动脉 心肌梗死 无复流现象 Thrombosis Suction Tirofiban Verapamil Angioplasty, transluminal, percutaneous coronary Myocardial infarction No - reflow phenomenon
  • 相关文献

参考文献3

二级参考文献32

  • 1朱小玲,王春梅,艾辉,高海,李南.直接经皮腔内冠状动脉内介入术中影响血栓抽吸有效性的因素分析[J].心肺血管病杂志,2010,29(S1):76-77. 被引量:2
  • 2YAN Hong-bing WANG Jian LI Nan ZHU Xiao-ling GAO Hai AI Hui LI Xiang YE Ming CHI Yun-peng ZHANG Hong.Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction:a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction[J].Chinese Medical Journal,2007(7):557-561. 被引量:29
  • 3[12]Antoniucci D,Migliorini A,Parodi G,et al.Abciximab-supported infarct artery stent imp-lantation for acute myocardial infarction and long-term survival:a prospective,multicenter,randomized trial comparing infarct artery stenting plus abciximab with stenting alone.Circulation,2004,109:1704-1706.
  • 4[13]Kern MJ,Aguirre F,Bach R,et al.Augmentation of coronary blood flow by inra-aortic balloon pumping in patients after coronary angiop lasty.Circulation,1993,87:500-511.
  • 5[14]Sutsch G,Kiowski W,Bossard A,et al.Use of an emboli containment and retrieval system during percutaneous coronary angiop lasty in native coronary arteries.J Invasive Cardiol,2002,14:C64-C72.
  • 6[1]Tanaka A,Kawarabayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion mophology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152.
  • 7[2]Jones CJ H,DeFily DV,Pat terson JL,et al.Endot helium-dependent relaxation competes with α1-and α2-adrenergic constriction in the canine epicardial coronary microcirculation.Circulation,1993,87:1264.
  • 8[3]Golino P,Ragni M,Cirillo P,et al.Recombinant human,active site blocked factor Ⅶ reduces infarct size and no-reflow phenomenon in atherosclerotic vascular disease.Circulation,2000,278:1507-1516.
  • 9[4]Baim D.On behalf of the SAFER investigators:transcatheter cardio-vascular therapeutics meeting.Washington DC,2000,October.
  • 10[5]Engler RL,Dahlgren MD,Morris DD,et al.Role of leukocytes in response to acute myocardial ischemia and reflow in dogs.Am J Physiol,1986,251:1131-1132.

共引文献49

同被引文献52

引证文献8

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部